Internal Medicine, Hematology · Chicago, IL
NPI
1790718617
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
675 N Saint Clair St, Galter 21-100
Chicago, IL, 60611
Phone (312) 695-0990
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
98,209 services
Medicare patients, 2024
1,286
Average age 73
Drug cost, 2024
$17.5M
6,902 prescriptions
Company payments, 2025
$1,013
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jayesh Mehta was code J9144 (injection, daratumumab, 10 mg and hyaluronidase-fihj), 13,140 times for 50 patients. In total Jayesh Mehta billed 98,209 services in 135 codes, and Medicare paid $2.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-07-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 13,140 | 50 | $39.26 | $516K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 12,500 | 14 | $2.32 | $29K |
| J9380 Injection, teclistamab-cqyv, 0.5 mg | Office | 10,404 | 20 | $24.65 | $256K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 6,046 | 16 | $0.05 | $319 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 4,600 | 32 | $0.24 | $1,083 |
| 99215 Office E&M - Established | Office | 3,534 | 769 | $144.54 | $511K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 3,530 | 48 | $36.35 | $128K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 3,450 | 18 | $0.12 | $398 |
| J9041 Injection, bortezomib, 0.1 mg | Office | 2,135 | 46 | $1.34 | $2,869 |
| J0897 Injection, denosumab, 1 mg | Office | 1,860 | 16 | $19.65 | $37K |
| J0461 Injection, atropine sulfate, 0.01 mg | Office | 740 | 14 | $0.07 | $50.14 |
| Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | Office | 710 | 12 | $20.47 | $15K |
| 99214 Office E&M - Established | Office | 688 | 336 | $98.97 | $68K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 622 | 41 | $0.09 | $55.79 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 530 | 41 | $0.64 | $338 |
By year: 2022 $1.9M for 61,134 services; 2023 $2.7M for 100,042 services; 2024 $2.7M for 98,209 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 84 | 69 | $8.65 | $727 |
Medicare prescription drug claims, 2024
In 2024, the drug Jayesh Mehta prescribed most often to Medicare patients was Acyclovir, with 990 prescriptions and refills. In total Jayesh Mehta wrote 6,902 Medicare prescriptions that cost $17.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 990 | 2,185 | 299 | $11K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 522 | 1,107 | 171 | $3,141 |
| Prednisone Generic | 404 | 635 | 141 | $2,364 |
| Revlimid Lenalidomide | 381 | 381 | 60 | $6.9M |
| Pomalyst Pomalidomide | 234 | 234 | 37 | $5.0M |
| Gabapentin Generic | 218 | 351 | 68 | $3,545 |
| Valacyclovir Valacyclovir Hcl | 215 | 434 | 66 | $9,033 |
| Ursodiol Generic | 181 | 257 | 50 | $21K |
| Pantoprazole Sodium Generic | 156 | 348 | 54 | $1,958 |
| Montelukast Sodium Generic | 143 | 319 | 56 | $1,541 |
| Omeprazole Generic | 138 | 347 | 59 | $1,522 |
| Jakafi Ruxolitinib Phosphate | 135 | 135 | 17 | $1.7M |
| Allopurinol Generic | 128 | 272 | 52 | $2,024 |
| Ondansetron Odt Ondansetron | 128 | 132 | 92 | $1,573 |
| Levofloxacin Generic | 119 | 121 | 88 | $1,402 |
Brand drugs: 1,408 claims; generic drugs: 5,480 claims; opioid claims: 110.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jayesh Mehta $1,013 ($1,013 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Biotech, Inc. with $1,013.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $1,013 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.